In 10 seconds? Bi-specific T cell engagers (BiTEs) are an emerging cancer treatment strategy that work both to activate anti-cancer T cells and pull them in to kill tumors. Wow, that sounds high-tech! And it is. BiTEs are essenti...
In 10 seconds? According to a recent study falling ill with COVID-19 does not guarantee that everyone would “seroconvert” against future infections by the coronavirus. This might be due to age or the amount of viral particles in t...
When we hear about SARS-CoV-2 immunity we mostly think: antibodies. These proteins are made by a group of immune cells, called B cells. Antibodies find and bind to foreign proteins in our bodies. They lock onto their targets, they...
Researchers have found small antibody fragments that could be promising in stopping the spread of SARS-CoV-2 infection if the favourable outcomes in animals translate to humans. Additionally, due to their size, they could be turne...
